Oral alendronate therapy for severe vitamin D intoxication of the infant with nephrocalcinosis

Basit Öğe Kaydı
dc.contributor.authorAtabek, ME
dc.contributor.authorPirgon, O
dc.contributor.authorSert, A
dc.date.accessioned2020-03-26T17:03:59Z
dc.date.available2020-03-26T17:03:59Z
dc.date.issued2006
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractVitamin D intoxication is a well-known cause of hypercalcemia in children. We report here the use of oral alendronate for the treatment of hypercalcemia due to vitamin D intoxication in a 7 month-old infant with nephrocalcinosis. The serum calcium levels were normalized without complications. Oral alendronate therapy may be safely used in hypercalcemia due to vitamin. D intoxication in pediatric patients with nephrocalcinosis resistant to hydration, diuretics or corticosteroids.en_US
dc.identifier.endpage172en_US
dc.identifier.issn0334-018Xen_US
dc.identifier.issue2en_US
dc.identifier.pmid16562591en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage169en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12395/20604
dc.identifier.volume19en_US
dc.identifier.wosWOS:000236264300011en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherFREUND PUBLISHING HOUSE LTDen_US
dc.relation.ispartofJOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISMen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectoral alendronate therapyen_US
dc.subjectinfanten_US
dc.subjectvitamin D intoxicationen_US
dc.titleOral alendronate therapy for severe vitamin D intoxication of the infant with nephrocalcinosisen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu